mRNA |
HLI 373 |
CTRPv2 |
pan-cancer |
AAC |
0.012 |
0.7 |
mRNA |
istradefylline |
CTRPv2 |
pan-cancer |
AAC |
0.019 |
0.7 |
mRNA |
BRD-K34099515 |
CTRPv2 |
pan-cancer |
AAC |
-0.025 |
0.7 |
mRNA |
austocystin d |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.7 |
mRNA |
UNC0321 |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.7 |
mRNA |
Topotecan |
CTRPv2 |
pan-cancer |
AAC |
-0.011 |
0.7 |
mRNA |
BRD8958 |
CTRPv2 |
pan-cancer |
AAC |
0.013 |
0.7 |
mRNA |
sitagliptin |
CTRPv2 |
pan-cancer |
AAC |
-0.024 |
0.7 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.011 |
0.7 |
mRNA |
selumetinib:MK-2206 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.012 |
0.7 |